Opt-out testing: who can afford to take care of patients with newly diagnosed HIV infection?

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Michael S Saag

Abstract

The appropriate adoption of a policy of opt-out universal testing for human immunodeficiency virus (HIV) will likely increase the number of new HIV-infected patients seeking care by at least 25% over the next several years. On the basis of recent analyses, this policy will save lives and reduce medical care costs. However, the majority of clinics are currently operating at maximum capacity and cannot absorb the influx of newly identified patients. Therefore, the implementation of the policy of opt-out testing will expose deficiencies in clinic capacity and will likely precipitate a crisis in health care access and delivery for patients seeking care at these clinics. A comprehensive assessment of the funding requirements of existing HIV clinics is urgently needed, and sufficient resources must be appropriated to ensure that existing clinics can expand their capacity to absorb the onslaught of HIV-infected patients newly identified via the opt-out testing policy.

References

Oct 21, 2005·The New England Journal of Medicine·Scott M Hammer
Mar 3, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ray Y ChenMichael S Saag
Aug 15, 2006·JAMA : the Journal of the American Medical Association·Scott M HammerUNKNOWN International AIDS Society-USA panel
Oct 20, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Michael S Saag
Apr 18, 2007·Annals of Internal Medicine·Myron S CohenLynn Paxton

❮ Previous
Next ❯

Citations

Jul 23, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ingrid V BassettRochelle P Walensky
Jan 12, 2010·AIDS Patient Care and STDs·James A McKinnellMichael S Saag
Jul 5, 2011·Journal of Zhejiang University. Science. B·Reinhard H DenninLan-juan Li
Jul 6, 2010·Public Health Reports·Jennifer L FaganA D McNaghten

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.